Editorials

Cost effective but unaffordable: an emerging challenge for health systems

BMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j1402 (Published 22 March 2017) Cite this as: BMJ 2017;356:j1402

Re: Cost effective but unaffordable: an emerging challenge for health systems

Fairness in implementation would be the critical aspect of this policy.

As long as NICE implements their "imperfect" proposal in a fair manner, many people might come around to supporting it.

A condition/disease (eg breast cancer) which has significantly more lobbying power should be treated in the same manner as a condition which has less lobbying power (eg ovarian cancer).

Competing interests: No competing interests

27 March 2017
S Sundar
Consultant Oncologist
Nottingham University Hospital NHS trust